Effects of fasudil on hypoxic pulmonary hypertension and pulmonary vascular remodeling in rats

被引：5
作者：
Sun, X. -Z. [1 ]
Tian, X. -Y. [2 ]
Wang, D. -W. [3 ]
Li, J. [3 ]
机构：
[1] Nanjing Med Univ, Huaian Peoples Hosp 1, Dept Pediat, Huaian, Peoples R China
[2] Nanjing Med Univ, Huaian Peoples Hosp 1, Dept Neurol, Huaian, Peoples R China
[3] Nanjing Med Univ, Affiliated Nanjing Childrens Hosp, Dept Cardiol, Nanjing, Jiangsu, Peoples R China
来源：
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES | 2014年 / 18卷 / 07期
关键词：
Fasudil; Pulmonary arterial hypertension (PAH); Pulmonary vascular remodeling; RHO-KINASE INHIBITOR; THERAPEUTIC TARGET;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
AIM: The aim of this study was to investigate the effects of Rho kinase inhibitor-Fasudil on hypoxic pulmonary hypertension (HPH) and pulmonary vascular remodeling in rats. MATERIALS AND METHODS: A total of 24 Sprague Dawley rats were evenly randomized into control, model and Fasudil intervention groups. Light and transmission electron microscopy were utilized to observe pulmonary vascular remodeling as well as ultrastructural changes in pulmonary arteriole endothelial cells. RESULTS: The model group showed apparent pulmonary vascular remodeling, pulmonary arteriole endothelial cell injury, the proliferation and swelling of smooth muscle cells around, and the proliferation of collagen fibers. Fasudil intervention improved pulmonary vascular remodeling as well as relieved pulmonary arteriole endothelial cell injury and the proliferation of smooth muscle cells and collagen fibers. CONCLUSIONS: Fasudil has preventive and reverse effects on HPH, pulmonary vascular remodeling, and pulmonary arteriole endothelial cell injury.
引用
收藏
页码：959 / 964
页数：6
相关论文
共 22 条
[1]   Targeting RhoA/ROCK pathway in pulmonary arterial hypertension [J].
Antoniu, Sabina Antonela .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 (04) :355-363
[2]   Analysis of pulmonary vasodilator responses to the Rho-kinase inhibitor fasudil in the anesthetized rat [J].
Badejo, Adeleke M., Jr. ;
Dhaliwal, Jasdeep S. ;
Casey, David B. ;
Gallen, Thomas B. ;
Greco, Anthony J. ;
Kadowitz, Philip J. .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2008, 295 (05) :L828-L836
[3]   New perspectives for the treatment of pulmonary hypertension [J].
Baliga, Reshma S. ;
MacAllister, Raymond J. ;
Hobbs, Adrian J. .
BRITISH JOURNAL OF PHARMACOLOGY, 2011, 163 (01) :125-140
[4]   RhoA/Rho-kinase signaling: a therapeutic target in pulmonary hypertension [J].
Barman, Scott A. ;
Zhu, Shu ;
White, Richard E. .
VASCULAR HEALTH AND RISK MANAGEMENT, 2009, 5 :663-671
[5]   Endothelial dysfunction in pulmonary hypertension [J].
Budhiraja, R ;
Tuder, RM ;
Hassoun, PM .
CIRCULATION, 2004, 109 (02) :159-165
[6]   Chronic hypoxia induces right heart failure in caveolin-1-/- mice [J].
Cruz, J. Agustin ;
Bauer, Eileen M. ;
Rodriguez, Andres I. ;
Gangopadhyay, Archana ;
Zeineh, Nabil S. ;
Wang, Yinna ;
Shiva, Sruti ;
Champion, Hunter C. ;
Bauer, Philip M. .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2012, 302 (12) :H2518-H2527
[7]   Pulmonary hypertension: From molecular pathophysiology to haemodynamic abnormalities [J].
Duong-Quy, S. ;
Riviere, S. ;
Bei, Y. ;
Duong-Ngo, C. ;
Le-Dong, N. N. ;
Hua-Huy, T. ;
Dinh-Xuan, A. T. .
REVUE DES MALADIES RESPIRATOIRES, 2012, 29 (08) :956-970
[8]   Hypoxia-induced pulmonary endothelin-1 expression is unaltered by nitric oxide [J].
Earley, S ;
Nelin, LD ;
Chicoine, LG ;
Walker, BR .
JOURNAL OF APPLIED PHYSIOLOGY, 2002, 92 (03) :1152-1158
[9]   Acute vasodilator effects of inhaled fasudil, a specific Rho-kinase inhibitor, in patients with pulmonary arterial hypertension [J].
Fujita, Hiroshi ;
Fukumoto, Yoshihiro ;
Saji, Kenya ;
Sugimura, Koichiro ;
Demachi, Jun ;
Nawata, Jun ;
Shimokawa, Hiroaki .
HEART AND VESSELS, 2010, 25 (02) :144-149
[10]   Recent Progress in the Management of Pulmonary Hypertension [J].
Fukumoto, Yoshihiro ;
Shimokawa, Hiroaki .
CIRCULATION JOURNAL, 2011, 75 (08) :1801-1810
123